Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study

Meyer L, Pothuri B (2006) Decompressive percutaneous gastrostomy tube use in gynecologic malignancies. Curr Treat Options Oncol 7:111–20

Pothuri B, Montemarano M, Gerardi M et al (2005) Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 96:330–4

Laval G, Arvieux C, Stefani L et al (2006) Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 31:502–12

Tsahalina E, Woolas RP, Carter PG et al (1999) Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstruction. Br J Obstet Gynaecol 106:964–8

Baines MJ (1998) The pathophysiology and management of malignant intestinal obstruction. In: Doyle D, Hanks GWC, MacDonald N (eds) Oxford textbook of palliative medicine. Oxford Univ, Oxford7, pp 526–34

Storey PS (1991) Obstruction of the GI tract. Am J Hospice Palliat Care 8:5

Ripamonti C, Easson AM, Gerdes H (2008) management of malignant bowel obstruction. Eur J Cancer 44(8):1105–1115

Malone JM Jr, Koonce T, Larson DM et al (1986) Palliation of small bowel obstruction by percutaneous gastrostomyin patients with progressive ovarian carcinoma. Obstet Gynecol 68:431–433

Stellato TA, Gauderer MW (1987) Percutaneous endoscopic gastrostomy for gastrointestinal decompression. Ann Surg 205(2):119–122

Cannizzaro R, Campagnutta E, De Piero G et al (1997) Percutaneous endoscopic gastrostomy/jejunostomy for decompression of intestinal obstruction by carcinomatosis in patients with total or subtotal gastrectomy. Ital J Gastroenterol Hepatol 29:A15

Campagnutta E, Cannizzaro R, Gallo A et al (1996) Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynaecol Oncol 62:103–105

Cannizzaro R, Bortoluzzi F, Valentini M et al (1995) Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis. Endoscopy 27:317–20

Campagnutta E, Cannizzaro R (2000) Percutaneous endoscopic gastrostomy (PEG) in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer: a review. Eur J Gynaecol Oncol 21:397–402

McClave SA, Ritchie CS (2006) The role of endoscopically placed feeding or decompression tubes. Gastroenterol Clin North Am 35:83–100

Hossein et al (2011) Acceptability and outcomes of percutaneous endoscopic gastrostomy (PEG) tube placement and quality of life. Turk J Gastoenterol 22(2):128–133

Gauderer MW, Ponsky JL, Izant RJ Jr (1980) Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatric Surg 15:872–875

McCorkle R, Young K (1978) Development of a symptom distress scale. Cancer Nurs 1(5):373–8

Peruselli C, Paci E (1993) SDS Symptom Distress Scale. In: Strumenti di Valutazione della Qualità di Vita (a cura di Tamburini M.). EdiSES, Napoli

Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63(2):364–67

Clarke Pearson DL, Chin NO, DeLong ER et al (1987) Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecol Oncol 26:11

Kawata N, Kakushima N, Tanaka M et al (2014) Percutaneous endoscopic gastrostomy for decompression of malignant bowel obstruction. Dig Endosc 26(2):208–13

Mangili G, Franchi M, Mariani A et al (1996) Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 61(3):345–8

Mercadante S, Porzio G. Octreotide for malignant bowel obstruction: twenty years after. Crit Rev Oncol Hematol 83(3). doi: 10.1016/j.critrevonc.2011.12.006 . Epub 2012 Review

Laval G, Rousselot H, Toussaint-Martel S et al (2012) SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction. SALTO Study Group. Bull Cancer 99(2):E1–9. doi: 10.1684/bdc.2011.153

Ripamonti C, Mercadante S (2004) How to use octreotide for malignant bowel obstruction. J Support Oncol 2(4):357–64

Shike M, Wallach C, Bloch A, Brennam MF (1990) Combined gastric drainage and jejunal feeding through a percutaneous endoscopic stoma. Gastrointest Endosc 36:290–293

Shike M, Wallach C, Likier H (1991) Direct percutaneous endoscopic jejunostomy. Gastrointest Endosc 37:62–65

Scheidbach H, Horbach T, Groitl H et al (1999) Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas. Surg Endosc 13:1103–5

Panzer S, Harris M, Berg W, Ravich W, Kalloo A (1995) Endoscopic ultrasound in the placement of a percutaneous endoscopic gastrostomy tube in the non transilluminated abdominal wall. Gastrointest Endosc 1:88–90

Vargo JJ, Germain M, Swenson JA, Harrison CR (1993) Ultrasound assisted percutaneous endoscopic gastrostomy in patient with advanced carcinoma and recurrent intestinal obstruction. Am J Gastroenterol 88:1946–1948

Vogt W, Messmann H, Lock G et al (1996) CT-guided percutaneous endoscopic gastrostomy in patients with unsuccessful endoscopic transillumination. Gastrointest Endosc 43:138–140

Ripamonti C, Twycross R, Baines M et al (2001) Working group of the European Association for Palliative Care. Support Care Cancer 9(4):223–33